Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Developing mechanically robust, triazole-zwitterionic hydrogels to mitigate foreign body response (FBR) for islet encapsulation.

Liu Q, Chiu A, Wang L, An D, Li W, Chen EY, Zhang Y, Pardo Y, McDonough SP, Liu L, Liu WF, Chen J, Ma M.

Biomaterials. 2020 Feb;230:119640. doi: 10.1016/j.biomaterials.2019.119640. Epub 2019 Nov 21.

PMID:
31791840
2.

Engineering transferrable microvascular meshes for subcutaneous islet transplantation.

Song W, Chiu A, Wang LH, Schwartz RE, Li B, Bouklas N, Bowers DT, An D, Cheong SH, Flanders JA, Pardo Y, Liu Q, Wang X, Lee VK, Dai G, Ma M.

Nat Commun. 2019 Oct 10;10(1):4602. doi: 10.1038/s41467-019-12373-5.

3.

Physical confinement induces malignant transformation in mammary epithelial cells.

Lu YC, Chu T, Hall MS, Fu DJ, Shi Q, Chiu A, An D, Wang LH, Pardo Y, Southard T, Danko CG, Liphardt J, Nikitin AY, Wu M, Fischbach C, Coonrod S, Ma M.

Biomaterials. 2019 Oct;217:119307. doi: 10.1016/j.biomaterials.2019.119307. Epub 2019 Jun 26.

PMID:
31271857
4.

Conformal Hydrogel Coatings on Catheters To Reduce Biofouling.

Yong Y, Qiao M, Chiu A, Fuchs S, Liu Q, Pardo Y, Worobo R, Liu Z, Ma M.

Langmuir. 2019 Feb 5;35(5):1927-1934. doi: 10.1021/acs.langmuir.8b03074. Epub 2018 Nov 29.

PMID:
30441901
5.

Scalable and Rechargeable Antimicrobial Coating for Food Safety Applications.

Qiao M, Liu Q, Yong Y, Pardo Y, Worobo R, Liu Z, Jiang S, Ma M.

J Agric Food Chem. 2018 Oct 31;66(43):11441-11450. doi: 10.1021/acs.jafc.8b03864. Epub 2018 Oct 17.

PMID:
30296071
6.

Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys.

Martí-Pastor M, Pont A, Ávila M, Garin O, Vilagut G, Forero CG, Pardo Y, Tresserras R, Medina-Bustos A, Garcia-Codina O, Cabasés J, Rajmil L, Alonso J, Ferrer M.

Popul Health Metr. 2018 Aug 16;16(1):14. doi: 10.1186/s12963-018-0170-8.

7.

Validity of the EQ-5D-5L and reference norms for the Spanish population.

Hernandez G, Garin O, Pardo Y, Vilagut G, Pont À, Suárez M, Neira M, Rajmil L, Gorostiza I, Ramallo-Fariña Y, Cabases J, Alonso J, Ferrer M.

Qual Life Res. 2018 Sep;27(9):2337-2348. doi: 10.1007/s11136-018-1877-5. Epub 2018 May 16.

PMID:
29767329
8.

Constant-Murley Score: systematic review and standardized evaluation in different shoulder pathologies.

Vrotsou K, Ávila M, Machón M, Mateo-Abad M, Pardo Y, Garin O, Zaror C, González N, Escobar A, Cuéllar R.

Qual Life Res. 2018 Sep;27(9):2217-2226. doi: 10.1007/s11136-018-1875-7. Epub 2018 May 10. Review.

9.

Assessing oral health-related quality of life in children and adolescents: a systematic review and standardized comparison of available instruments.

Zaror C, Pardo Y, Espinoza-Espinoza G, Pont À, Muñoz-Millán P, Martínez-Zapata MJ, Vilagut G, Forero CG, Garin O, Alonso J, Ferrer M.

Clin Oral Investig. 2019 Jan;23(1):65-79. doi: 10.1007/s00784-018-2406-1. Epub 2018 Mar 22.

PMID:
29569021
10.

Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes.

An D, Chiu A, Flanders JA, Song W, Shou D, Lu YC, Grunnet LG, Winkel L, Ingvorsen C, Christophersen NS, Fels JJ, Sand FW, Ji Y, Qi L, Pardo Y, Luo D, Silberstein M, Fan J, Ma M.

Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E263-E272. doi: 10.1073/pnas.1708806115. Epub 2017 Dec 26.

11.

Impact of traumatic dental injuries on quality of life in preschoolers and schoolchildren: A systematic review and meta-analysis.

Zaror C, Martínez-Zapata MJ, Abarca J, Díaz J, Pardo Y, Pont À, Ferrer M.

Community Dent Oral Epidemiol. 2018 Feb;46(1):88-101. doi: 10.1111/cdoe.12333. Epub 2017 Sep 21.

PMID:
28940434
12.

High-water-content and resilient PEG-containing hydrogels with low fibrotic response.

Zhang Y, An D, Pardo Y, Chiu A, Song W, Liu Q, Zhou F, McDonough SP, Ma M.

Acta Biomater. 2017 Apr 15;53:100-108. doi: 10.1016/j.actbio.2017.02.028. Epub 2017 Feb 20.

PMID:
28216297
13.

Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review.

Becerra V, Ávila M, Jimenez J, Cortes-Sanabria L, Pardo Y, Garin O, Pont A, Alonso J, Cots F, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer.

BMC Health Serv Res. 2016 Oct 3;16(1):541. Review.

14.

Dynamic self-organization of microwell-aggregated cellular mixtures.

Song W, Tung CK, Lu YC, Pardo Y, Wu M, Das M, Kao DI, Chen S, Ma M.

Soft Matter. 2016 Jun 29;12(26):5739-46. doi: 10.1039/c6sm00456c.

PMID:
27275624
15.

A Community-Academic Partnered Grant Writing Series to Build Infrastructure for Partnered Research.

King KM, Pardo YJ, Norris KC, Diaz-Romero M, Morris D, Vassar SD, Brown AF.

Clin Transl Sci. 2015 Oct;8(5):573-8. doi: 10.1111/cts.12327. Epub 2015 Sep 13.

16.

Detection of outer membrane vesicles in Synechocystis PCC 6803.

Pardo YA, Florez C, Baker KM, Schertzer JW, Mahler GJ.

FEMS Microbiol Lett. 2015 Oct;362(20). pii: fnv163. doi: 10.1093/femsle/fnv163. Epub 2015 Sep 10.

17.

Estimating preferences for treatments in patients with localized prostate cancer.

Ávila M, Becerra V, Guedea F, Suárez JF, Fernandez P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Cunillera O, Pardo Y, Cots F, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer.

Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):277-87. doi: 10.1016/j.ijrobp.2014.09.044. Epub 2014 Dec 6.

PMID:
25491504
18.

Obtaining Indirect Utilities with the Sf-6d and the Porpus-U in Prostate Cancer Patients.

Avila MM, Pardo Y, Castells M, Ferrer F, Boladeras A, Pera J, Prada P, Guix B, de Paula B, Hernandez H, Pont A, Alonso J, Garin O, Ferrer M.

Value Health. 2014 Nov;17(7):A646. doi: 10.1016/j.jval.2014.08.2342. Epub 2014 Oct 26. No abstract available.

19.

Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS).

Avila M, Pardo Y, Castells M, Ferrer F, Boladeras A, Pera J, Prada PJ, Guix B, de Paula B, Hernandez H, Pont A, Alonso J, Garin O, Bremner K, Krahn M, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer.

Qual Life Res. 2014 Nov;23(9):2481-7. doi: 10.1007/s11136-014-0701-0. Epub 2014 May 1.

PMID:
24789667
20.

Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.

Schmidt S, Garin O, Pardo Y, Valderas JM, Alonso J, Rebollo P, Rajmil L, Garcia-Forero C, Ferrer M; EMPRO Group.

Qual Life Res. 2014 Oct;23(8):2169-81. doi: 10.1007/s11136-014-0678-8. Epub 2014 Apr 19.

21.

Increased cut-point of the TACER-3 screen reduces false positives without losing sensitivity in predicting risk alcohol drinking in pregnancy.

Chiodo LM, Delaney-Black V, Sokol RJ, Janisse J, Pardo Y, Hannigan JH.

Alcohol Clin Exp Res. 2014 May;38(5):1401-8. doi: 10.1111/acer.12368. Epub 2014 Mar 21.

PMID:
24655071
22.

Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.

Ferrer M, Guedea F, Suárez JF, de Paula B, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Boladeras A, Ayala A, Craven-Bratle J, Ávila M, Cunillera O, Pardo Y, Alonso J, Aguiló F; Clinically Localized Prostate Cancer.

Radiother Oncol. 2013 Aug;108(2):306-13. doi: 10.1016/j.radonc.2013.05.038. Epub 2013 Jul 9.

PMID:
23849168
23.

Psychometric analysis of the Catalan version of the Alabama Parenting Questionnaire (APQ) in a community sample.

Molinuevo B, Pardo Y, Torrubia R.

Span J Psychol. 2011 Nov;14(2):944-55.

PMID:
22059338
24.

[Cost comparison of three treatments for localized prostate cancer in Spain: radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy].

Becerra Bachino V, Cots F, Guedea F, Pera J, Boladeras A, Aguiló F, Suárez JF, Gallo P, Murgui L, Pont A, Cunillera O, Pardo Y, Ferrer M; Grupo Multicéntrico Español de Cáncer de Próstata Organoconfinado.

Gac Sanit. 2011 Jan-Feb;25(1):35-43. doi: 10.1016/j.gaceta.2010.10.008. Spanish.

25.

Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.

Pardo Y, Guedea F, Aguiló F, Fernández P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Craven-Bratle J, Suárez JF, Boladeras A, Pont À, Ayala A, Sancho G, Martínez E, Alonso J, Ferrer M.

J Clin Oncol. 2010 Nov 1;28(31):4687-96. doi: 10.1200/JCO.2009.25.3245. Epub 2010 Oct 4. Erratum in: J Clin Oncol. 2011 Feb 20;29(6):779.

PMID:
20921463
26.

Treatment of localised prostate cancer with radiation therapy: evidence versus opinion.

Guedea F, Ramos A, Herruzo I, Sánchez Calzado JA, Contreras J, Romero J, Craven-Bartle J, Willisch P; SEOR (Spanish Society of Radiation Oncology), López Torrecilla JL, Maldonado X, Sancho G, Zapatero A; UROONCOR (Prostate Group of SEOR), Ferrer M, Pardo Y, Fernández P, Mariño A, Hervás A, Macís V, Boladeras A, Ferrer F; Multicentric Spanish Group of Clinically Localized Prostate Cancer, Davis BJ.

Clin Transl Oncol. 2010 May;12(5):315-7. No abstract available.

PMID:
20466614
27.

Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey.

Cunillera O, Tresserras R, Rajmil L, Vilagut G, Brugulat P, Herdman M, Mompart A, Medina A, Pardo Y, Alonso J, Brazier J, Ferrer M.

Qual Life Res. 2010 Aug;19(6):853-64. doi: 10.1007/s11136-010-9639-z. Epub 2010 Mar 31.

PMID:
20354795
28.

Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.

Guedea F, Ferrer M, Pera J, Aguiló F, Boladeras A, Suárez JF, Cunillera O, Ferrer F, Pardo Y, Martínez E, Ventura M.

Clin Transl Oncol. 2009 Jul;11(7):470-8.

PMID:
19574206
29.

Alcohol use as a behavioural sign of disinhibition: evidence from J.A. Gray's model of personality.

Pardo Y, Aguilar R, Molinuevo B, Torrubia R.

Addict Behav. 2007 Oct;32(10):2398-403. Epub 2007 Mar 7.

PMID:
17407802
30.

Impact of lower urinary tract symptoms on quality of life using Functional Assessment Cancer Therapy scale.

Batista-Miranda JE, Molinuevo B, Pardo Y.

Urology. 2007 Feb;69(2):285-8.

PMID:
17320665
31.

Levonorgestrel-releasing intrauterine system as an adjunct to estrogen for the treatment of menopausal symptoms--a review.

Peled Y, Perri T, Pardo Y, Kaplan B.

Menopause. 2007 May-Jun;14(3 Pt 1):550-4. Review.

PMID:
17224852
32.

[Effect of some biocides on non-tuberculous mycobacteria].

León CI, Pardo YP, Ramírez CX.

Biomedica. 2002 Jun;22(2):133-40. Spanish.

PMID:
12152479
33.

Exercise conditioning and heart rate variability: evidence of a threshold effect.

Pardo Y, Merz CN, Velasquez I, Paul-Labrador M, Agarwala A, Peter CT.

Clin Cardiol. 2000 Aug;23(8):615-20.

34.

Mental versus physical stress, QT prolongation, and the autonomic nervous system.

Merz CN, Pardo Y.

Circulation. 2000 Jun 6;101(22):E213-4. No abstract available.

PMID:
10840023
35.

Pregnancy outcome in women with primary renal disease.

Bar J, Orvieto R, Shalev Y, Peled Y, Pardo Y, Gafter U, Ben-Rafael Z, Chen R, Hod M.

Isr Med Assoc J. 2000 Feb;2(2):178-81.

36.

Compliance with hormone replacement therapy in postmenopausal women. A comparative study.

Goldman GA, Kaplan B, Leiserowitz DM, Pardo Y, Amster R, Fisch B.

Clin Exp Obstet Gynecol. 1998;25(1-2):18-9.

PMID:
9743872
37.

Heart rate variability reproducibility and stability using commercially available equipment in coronary artery disease with daily life myocardial ischemia.

Pardo Y, Merz CN, Paul-Labrador M, Velasquez I, Gottdiener JS, Kop WJ, Krantz DS, Rozanski A, Klein J, Peter T.

Am J Cardiol. 1996 Oct 15;78(8):866-70.

PMID:
8888656
38.

Circadian variation of ambulatory myocardial ischemia. Triggering by daily activities and evidence for an endogenous circadian component.

Krantz DS, Kop WJ, Gabbay FH, Rozanski A, Barnard M, Klein J, Pardo Y, Gottdiener JS.

Circulation. 1996 Apr 1;93(7):1364-71.

PMID:
8641025
39.

Low dose estrogen replacement therapy in early postmenopausal women effect on urinary magnesium and calcium: creatinine ratios.

Kaplan B, Neri A, Kitai E, Pardo Y, Blum M, Friedman J.

Clin Exp Obstet Gynecol. 1994;21(3):170-2.

PMID:
7923797
40.

The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women.

Bar J, Tepper R, Fuchs J, Pardo Y, Goldberger S, Ovadia J.

Obstet Gynecol. 1993 Feb;81(2):261-4.

PMID:
8380912
41.

Effect of sex hormones on human T cell activation by concanavalin A.

Yron I, Langer A, Weinstein T, Sahar E, Lidor Y, Pardo Y, Katz I, Shohat L, Kalechman Y, Ovadia J, et al.

Nat Immun Cell Growth Regul. 1991;10(1):32-44.

PMID:
2057020
42.

Frequency and activity of autorosette forming cells in Con-A activated PBL from women with hyperplasia or carcinoma of the endometrium--possible role of estrogens.

Yron I, Kalechman Y, Langer A, Lidor I, Luria B, Luria H, Ovadia J, Pardo Y, Shohat L.

J Clin Lab Immunol. 1990 Nov;33(3):135-43.

PMID:
1967003
43.

Premature separation of placenta in a patient with idiopathic thrombocytopenic purpura.

Neri A, Pardo Y, Schoenfeld A, Zaizov R, Cohen IJ.

Fetal Ther. 1989;4(4):185-7.

PMID:
2484940
44.

Effects of verapamil and bepridil on occlusion and reperfusion arrhythmias in the canine heart.

Pelleg A, Pardo Y, Belhassen B, Shargordsky B, Chagnac A, Laniado S.

Cardiology. 1985;72(4):193-201.

PMID:
3876883
45.

[Early insertion of the IUD soon after childbirth].

Wajntraub G, Stark M, Pardo Y.

Minerva Ginecol. 1981 Apr;33(4):351-4. Italian.

PMID:
7243078
46.

[Advances in the research of the contraceptive action of LH-RH analogs].

Pardo Y, Wajntraub G.

Harefuah. 1980 Oct 15;99(8):229-31. Hebrew. No abstract available.

PMID:
7011919
47.

[A further case of hydatidiform mole after treatment with clomiphene].

Wajntraub G, Pardo Y.

Minerva Ginecol. 1978 Sep;30(9):759-62. Italian. No abstract available.

PMID:
568226
48.

[Pregnancy in myotonic dystrophy].

Weiss DB, Aboulafia Y, Isacsohn M, Pardo Y.

Harefuah. 1977 Jun 15;92(12):566-8. Hebrew. No abstract available.

PMID:
560337
49.

Proceedings: Hormone determination as a tool for prenatal diagnosis of anencephalic fetus.

Pardo Y, Kauffman R, Eylath U, Aboulaffia Y.

Isr J Med Sci. 1975 Nov;11(11):1221. No abstract available.

PMID:
1205818
50.

[Vaginal polyposis].

Pardo Y, Wajntraub G, Dollberg L.

Minerva Ginecol. 1975 Nov;27(11):878-81. Italian. No abstract available.

PMID:
1187063

Supplemental Content

Support Center